专利检索 ap:("Hoffmann-La Roche Inc.") AND inv:"Laura CODARRI DEAK" 第 1 页

1.

发明申请
Combination therapy of PD-1-targeted IL-2 variant immunocytokines and antibodies against human PD-L1 有权

公开(公告)号：US20220072103A1

公开(公告)日：2022-03-10

申请号：US17464518

申请日：2021-09-01

申请人： Hoffmann-La Roche Inc.

发明人： Laura CODARRI DEAK , Douglas Hanahan , Christian Klein , Valeria Nicolini , Pablo Umana , Stephen Wullschleger

IPC分类号： A61K38/20 , A61K39/395 , A61K35/17 , A61K35/15 , A61K38/17 , A61P35/00

摘要： The present invention relates to the combination therapy of specific PD-1-targeted IL-2 variant immunocytokines with specific antibodies which bind human PD-L1.

2.

发明申请
ANTI-LAG3 ANTIBODIES 审中-公开

公开(公告)号：US20200277372A1

公开(公告)日：2020-09-03

申请号：US16590628

申请日：2019-10-02

申请人： Hoffmann-La Roche Inc.

发明人： Laura CODARRI DEAK , Stefan C. DENGL , Jens FISCHER , Christian KLEIN , Stefan SEEBER , Patrick Alexander Aaron WEBER , Adrian Zwick

IPC分类号： C07K16/28

摘要： The present invention relates to anti-LAG3 antibodies, to methods of producing these molecules and methods of using the same.